BMO starts Nike stock coverage at underperform on margin concerns

BMO Capital initiated Nike at Underperform with a $30 price target, implying roughly 21% downside from its $38.11 trading price, and expects a full EPS recovery to about $3.00 only by fiscal 2031. The firm cited slowing lifestyle demand, a China distribution reset and structurally lower margins, and expects Nike to reset FY2027 expectations with its October 1 earnings report. Nike shares have already fallen 46.5% over the past year and trade near their 52-week low, while a CFO transition and interim controller appointment add to the near-term uncertainty.

Analysis

The investable issue is not near-term demand alone but the duration of Nike’s margin repair cycle. A wholesale-channel reset and heavier marketplace investment can simultaneously depress sell-in, elevate promotional expense, and dilute gross margin; that creates a multi-quarter earnings de-risking process rather than a single bad guidance print. DKS’s weaker outlook is an important read-through because it raises the probability that wholesale partners demand more markdown support and tighter inventory commitments heading into holiday and spring orders.

NKE’s downside is most acute through the October earnings reset, when the market will test whether consensus still embeds a recovery trajectory inconsistent with channel conditions. The November investor day is a secondary catalyst, but it can only stabilize the multiple if management provides measurable milestones on gross margin, China inventory, and wholesale order growth; broad brand-strategy commentary will not be enough. The interim-controller transition is not independently thesis-changing, but it increases scrutiny on the credibility and timing of reserve, inventory, and margin assumptions during a reset.

A second-order beneficiary is ADS.DE, which has greater opportunity to retain shelf space and consumer attention while Nike rationalizes distribution, although broad athletic-footwear promotion limits absolute upside for the whole category. The contrarian case is that NKE’s drawdown already reflects a weak consumer backdrop and that reduced expectations set up a relief rally on merely "less bad" guidance. That view is falsified if October guidance implies another year of gross-margin pressure or if wholesale accounts signal continued order conservatism; conversely, sustained full-price sell-through and a clear China inventory normalization would invalidate the short thesis.

Key Decisions for Investors

• Initiate a tactical NKE short ahead of the October 1 earnings event, targeting $30 over 1-3 months versus a $42 stop/cover level. The setup offers roughly 2:1 downside-to-upside risk from the cited trading range; size modestly because depressed expectations make a relief rally plausible.
• For defined-risk exposure, buy NKE November or January put spreads centered around $35/$30 rather than outright puts. This isolates the guidance-reset and investor-day windows while avoiding excessive premium paid for a deeper, low-probability collapse.
• Express relative share-shift risk via long ADS.DE / short NKE over the next 3-6 months, initially dollar-neutral. Exit the pair if Nike demonstrates sequential improvement in full-price sell-through and wholesale order trends, or if Adidas begins guiding to material promotional pressure.
• Monitor DKS holiday inventory commentary and Nike’s reported gross-margin outlook as confirmation signals. A constructive DKS inventory/order update or Nike margin guidance that improves without incremental discounting would warrant reducing the NKE short before the investor day.